TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $223,457 | +80.2% | 18,889 | -9.7% | 0.01% | +57.1% |
Q3 2022 | $124,000 | -80.1% | 20,914 | -55.9% | 0.01% | -53.3% |
Q2 2018 | $624,000 | -24.8% | 47,454 | -18.8% | 0.02% | -25.0% |
Q1 2018 | $830,000 | +55.7% | 58,421 | -10.1% | 0.02% | +66.7% |
Q4 2017 | $533,000 | +75.3% | 64,957 | +153.1% | 0.01% | +71.4% |
Q3 2017 | $304,000 | +17.8% | 25,662 | 0.0% | 0.01% | +16.7% |
Q2 2017 | $258,000 | – | 25,662 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |